يعرض 1 - 10 نتائج من 44 نتيجة بحث عن '"Christian U Blank"', وقت الاستعلام: 0.72s تنقيح النتائج
  1. 1
    Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma

    المؤلفون: Alexander C J, van Akkooi, Tina J, Hieken, Elizabeth M, Burton, Charlotte, Ariyan, Paolo A, Ascierto, Salvatore V M A, Asero, Christian U, Blank, Matthew S, Block, Genevieve M, Boland, Corrado, Caraco, Sydney, Chng, B Scott, Davidson, Joao Pedreira, Duprat Neto, Mark B, Faries, Jeffrey E, Gershenwald, Dirk J, Grunhagen, David E, Gyorki, Dale, Han, Andrew J, Hayes, Winan J, van Houdt, Giorgos C, Karakousis, Willem M C, Klop, Georgina V, Long, Michael C, Lowe, Alexander M, Menzies, Roger, Olofsson Bagge, Thomas E, Pennington, Piotr, Rutkowski, Robyn P M, Saw, Richard A, Scolyer, Kerwin F, Shannon, Vernon K, Sondak, Hussein, Tawbi, Alessandro A E, Testori, Mike T, Tetzlaff, John F, Thompson, Jonathan S, Zager, Charlotte L, Zuur, Jennifer A, Wargo, Andrew J, Spillane, Merrick I, Ross

    المساهمون: Surgery

    المصدر: Annals of Surgical Oncology, 29(6), 3694-3708. Springer New York

    مصطلحات موضوعية: Skin Neoplasms, Oncology, Humans, Surgery, Melanoma, Neoadjuvant Therapy

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9e872abd5d1a96ea257aff63c3b671cTest
    https://doi.org/10.1245/s10434-021-11236-yTest


    أضف إلى المفضلة
  2. 2
    Response to immune checkpoint inhibitors in acral melanoma

    المؤلفون: Olivier J. van Not, Melissa M. de Meza, Alfons J.M. van den Eertwegh, John B. Haanen, Christian U. Blank, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Jesper van Breeschoten, Jan-Willem B. de Groot, Geke A.P. Hospers, Rawa K. Ismail, Ellen Kapiteijn, Djura Piersma, Roos S. van Rijn, Marion A.M. Stevense-den Boer, Astrid A.M. van der Veldt, Gerard Vreugdenhil, Han J. Bonenkamp, Marye J. Boers-Sonderen, Willeke A.M. Blokx, Michel W.J.M. Wouters, Karijn P.M. Suijkerbuijk

    المساهمون: Medical Oncology, Radiology & Nuclear Medicine, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Internal medicine, Medical oncology, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, Obstetrics and gynaecology, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

    المصدر: European journal of cancer (Oxford, England : 1990), 167, 70-80. Elsevier Ltd.
    van Not, O J, de Meza, M M, van den Eertwegh, A J M, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, van Breeschoten, J, de Groot, J-W B, Hospers, G A P, Ismail, R K, Kapiteijn, E, Piersma, D, van Rijn, R S, Stevense-den Boer, M A M, van der Veldt, A A M, Vreugdenhil, G, Bonenkamp, H J, Boers-Sonderen, M J, Blokx, W A M, Wouters, M W J M & Suijkerbuijk, K P M 2022, ' Response to immune checkpoint inhibitors in acral melanoma : A nationwide cohort study ', European Journal of Cancer, vol. 167, pp. 70-80 . https://doi.org/10.1016/j.ejca.2022.02.026Test
    European Journal of Cancer, 167, 70-80. ELSEVIER SCI LTD
    European Journal of Cancer, 167, pp. 70-80
    European Journal of Cancer, 167, 70-80
    European Journal of Cancer, 167, 70-80. Pergamon

    مصطلحات موضوعية: Cancer Research, Skin Neoplasms, Survival, Melanoma/mortality, THERAPY, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], SUBTYPES, Cohort Studies, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], Immune checkpoint inhibitors, All institutes and research themes of the Radboud University Medical Center, SDG 3 - Good Health and Well-being, Skin Neoplasms/drug therapy, Humans, Prospective Studies, Melanoma, OUTCOMES, Response, KIT, EFFICACY, Nivolumab/adverse effects, Ipilimumab, Immune Checkpoint Inhibitors/therapeutic use, MUCOSAL, Nivolumab, Oncology, ARM, Immunotherapy, Ipilimumab/therapeutic use

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85e0333d1ed14f8c5e0b759f512b98e9Test
    http://www.scopus.com/inward/record.url?scp=85127559750&partnerID=8YFLogxKTest


    أضف إلى المفضلة
  3. 3
    MeVa2.1.dOVA and MeVa2.2.dOVA: two novel BRAFV600E-driven mouse melanoma cell lines to study tumor immune resistance

    المؤلفون: Disha Rao, Ruben Lacroix, Alex Rooker, Tainá Gomes, Johanna A. Stunnenberg, Mesele Valenti, Petros Dimitriadis, Chun-Pu Lin, Beaunelle de Bruijn, Oscar Krijgsman, Maarten A. Ligtenberg, Daniel S. Peeper, Christian U. Blank

    المصدر: Melanoma research. 33(1)

    مصطلحات موضوعية: Cancer Research, Mice, Skin Neoplasms, Oncology, Cell Line, Tumor, Animals, Dermatology, Immunotherapy, CD8-Positive T-Lymphocytes, Antigens, Melanoma

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a54c84207dd27e435fa15d14344b1d54Test
    https://pubmed.ncbi.nlm.nih.gov/36545919Test


    أضف إلى المفضلة
  4. 4
    Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma

    المؤلفون: Irene L. M. Reijers, Alexander M. Menzies, Alexander C. J. van Akkooi, Judith M. Versluis, Noëlle M. J. van den Heuvel, Robyn P. M. Saw, Thomas E. Pennington, Ellen Kapiteijn, Astrid A. M. van der Veldt, Karijn P. M. Suijkerbuijk, Geke A. P. Hospers, Elisa A. Rozeman, Willem M. C. Klop, Winan J. van Houdt, Karolina Sikorska, Jos A. van der Hage, Dirk J. Grünhagen, Michel W. Wouters, Arjen J. Witkamp, Charlotte L. Zuur, Judith M. Lijnsvelt, Alejandro Torres Acosta, Lindsay G. Grijpink-Ongering, Maria Gonzalez, Katarzyna Jóźwiak, Carolien Bierman, Kerwin F. Shannon, Sydney Ch’ng, Andrew J. Colebatch, Andrew J. Spillane, John B. A. G. Haanen, Robert V. Rawson, Bart A. van de Wiel, Lonneke V. van de Poll-Franse, Richard A. Scolyer, Annelies H. Boekhout, Georgina V. Long, Christian U. Blank

    المساهمون: Medical and Clinical Psychology, Oral and Maxillofacial Surgery, Medical Oncology, Radiology & Nuclear Medicine, Surgery, Guided Treatment in Optimal Selected Cancer Patients (GUTS)

    المصدر: Nature Medicine, 28(6), 1178-+. NATURE PORTFOLIO
    Nature Medicine, 28(6), 1178-1188. Nature Publishing Group
    Nature Medicine
    Nature medicine, 28(6), 1178-1188. Nature Publishing Group
    Nature Medicine, 28. Nature Publishing Group

    مصطلحات موضوعية: Skin Neoplasms, General Medicine, BIOMARKER ANALYSES, Ipilimumab, Neoadjuvant Therapy, General Biochemistry, Genetics and Molecular Biology, MORBIDITY, Nivolumab, QUALITY-OF-LIFE, Antineoplastic Combined Chemotherapy Protocols, Quality of Life, BIOPSY, SURVIVAL, Humans, AXILLARY, Neoplasm Recurrence, Local, IMMUNOTHERAPY, Melanoma, DISSECTION, SENTINEL LYMPH-NODE, Neoplasm Staging

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67d79d3cfe1f3c168f561afa30efdc6cTest
    https://doi.org/10.1038/s41591-022-01851-xTest


    أضف إلى المفضلة
  5. 5
    The unfavorable effects of COVID-19 on Dutch advanced melanoma care

    المؤلفون: Christian U. Blank, John B. A. G. Haanen, Doranne L. Hilarius, Michel W. J. M. Wouters, Willeke A. M. Blokx, Franchette W P J van den Berkmortel, Ellen Kapiteijn, Rawa K. Ismail, Geke A. P. Hospers, Jesper van Breeschoten, Alfonsus J. M. van den Eertwegh, Rozemarijn S. van Rijn, Jan Willem B. de Groot, Maureen J.B. Aarts, D Piersma, Astrid A M van der Veldt, G. Vreugdenhil, Marion A. M. Stevense-den Boer, Marye Boers-Sonderen, Karijn P M Suijkerbuijk, Olivier J. van Not, Melissa M. De Meza

    المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Medical Oncology, Radiology & Nuclear Medicine, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Internal medicine, Medical oncology, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, Obstetrics and gynaecology, Amsterdam Reproduction & Development (AR&D)

    المصدر: International Journal of Cancer, 150(5), 816-824. Wiley
    van Not, O J, van Breeschoten, J, van den Eertwegh, A J M, Hilarius, D L, de Meza, M M, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J W B, Hospers, G A P, Ismail, R K, Kapiteijn, E, Piersma, D, van Rijn, R S, Stevense-den Boer, M A M, van der Veldt, A A M, Vreugdenhil, G, Boers-Sonderen, M J, Blokx, W A M, Suijkerbuijk, K P M & Wouters, M W J M 2022, ' The unfavorable effects of COVID-19 on Dutch advanced melanoma care ', International Journal of Cancer, vol. 150, no. 5, pp. 816-824 . https://doi.org/10.1002/ijc.33833Test
    International Journal of Cancer, 150, 816-824
    International Journal of Cancer, 150, 5, pp. 816-824
    International Journal of Cancer, 150(5), 816-824. Wiley-Liss Inc.
    International Journal of Cancer, 150(5), 816-824. WILEY
    International Journal of Cancer

    مصطلحات موضوعية: Adult, Male, advanced melanoma, Cancer Research, Pediatrics, medicine.medical_specialty, Skin Neoplasms, Coronavirus disease 2019 (COVID-19), IMPACT, nationwide registry, Medical care, Systemic therapy, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], systemic therapy, SDG 3 - Good Health and Well-being, COVID‐19, Humans, Medicine, Stage IIIC, Cancer Therapy and Prevention, Melanoma, Aged, Netherlands, Advanced melanoma, Aged, 80 and over, Control period, Performance status, SARS-CoV-2, business.industry, COVID-19, Middle Aged, medicine.disease, clinical outcomes, Oncology, Female, business

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6999d1436b905ac42aa992a91b031b28Test
    https://hdl.handle.net/2066/244556Test


    أضف إلى المفضلة
  6. 6
    Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma

    المؤلفون: Prachi Bhave, Tasnia Ahmed, Serigne N Lo, Alexander Shoushtari, Anne Zaremba, Judith M Versluis, Joanna Mangana, Michael Weichenthal, Lu Si, Thierry Lesimple, Caroline Robert, Claudia Trojanello, Alexandre Wicky, Richard Heywood, Lena Tran, Kathleen Batty, Florentia Dimitriou, Anna Stansfeld, Clara Allayous, Julia K Schwarze, Meghan J Mooradian, Oliver Klein, Inderjit Mehmi, Rachel Roberts-Thomson, Andrea Maurichi, Hui-Ling Yeoh, Adnan Khattak, Lisa Zimmer, Christian U Blank, Egle Ramelyte, Katharina C Kähler, Severine Roy, Paolo A Ascierto, Olivier Michielin, Paul C Lorigan, Douglas B Johnson, Ruth Plummer, Celeste Lebbe, Bart Neyns, Ryan Sullivan, Omid Hamid, Mario Santinami, Grant A McArthur, Andrew M Haydon, Georgina V Long, Alexander M Menzies, Matteo S Carlino

    المساهمون: Clinical sciences, Laboratory of Molecular and Medical Oncology, Internal Medicine, Faculty of Medicine and Pharmacy, Medical Oncology

    المصدر: Bhave, P, Ahmed, T, Lo, S N, Shoushtari, A, Zaremba, A, Versluis, J M, Mangana, J, Weichenthal, M, Si, L, Lesimple, T, Robert, C, Trojanello, C, Wicky, A, Heywood, R, Tran, L, Batty, K, Dimitriou, F, Stansfeld, A, Allayous, C, Schwarze, J K, Mooradian, M J, Klein, O, Mehmi, I, Roberts-Thomson, R, Maurichi, A, Yeoh, H L, Khattak, A, Zimmer, L, Blank, C U, Ramelyte, E, Kähler, K C, Roy, S, Ascierto, P A, Michielin, O, Lorigan, P C, Johnson, D B, Plummer, R, Lebbe, C, Neyns, B, Sullivan, R, Hamid, O, Santinami, M, McArthur, G A, Haydon, A M, Long, G V, Menzies, A M & Carlino, M S 2022, ' Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma ', Journal for ImmunoTherapy of Cancer, vol. 10, no. 7, e004668 . https://doi.org/10.1136/jitc-2022-004668Test

    مصطلحات موضوعية: Pharmacology, Cancer Research, Skin Neoplasms, Manchester Cancer Research Centre, ResearchInstitutes_Networks_Beacons/mcrc, Immunology, Programmed Cell Death 1 Receptor, Medizin, Ipilimumab, oncology, Molecular Medicine, Immunology and Allergy, Humans, CTLA-4 Antigen, Immunotherapy, immunotherapy, Prospective Studies, Melanoma, Retrospective Studies

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92b5a9d00012b0583c371b3485e31ff2Test
    https://pubmed.ncbi.nlm.nih.gov/35793872Test


    أضف إلى المفضلة
  7. 7
    Diagnostic performance of early increase in S100B or LDH as outcome predictor for non-responsiveness to anti-PD-1 monotherapy in advanced melanoma

    المؤلفون: Elisa A. Rozeman, Judith M. Versluis, Ruben Moritz, Sofie Wilgenhof, Johannes V. van Thienen, John B.A.G. Haanen, Michel M. van de Heuvel, Christian U. Blank, Huub H. van Rossum

    المصدر: Clinica chimica acta; international journal of clinical chemistry. 533

    مصطلحات موضوعية: Skin Neoplasms, L-Lactate Dehydrogenase, Biochemistry (medical), Clinical Biochemistry, Programmed Cell Death 1 Receptor, General Medicine, S100 Calcium Binding Protein beta Subunit, Prognosis, Biochemistry, Antibodies, Biomarkers, Tumor, Humans, Prospective Studies, Melanoma, Retrospective Studies

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6a442d4da402e3741825f223a108b67Test
    https://pubmed.ncbi.nlm.nih.gov/35709988Test


    أضف إلى المفضلة
  8. 8
    Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma

    المؤلفون: Irene L. M. Reijers, Robert V. Rawson, Andrew J. Colebatch, Elisa A. Rozeman, Alex M. Menzies, Alexander C. J. van Akkooi, Kerwin F. Shannon, Michel W. Wouters, Robyn P. M. Saw, Winan J. van Houdt, Charlotte L. Zuur, Omgo E. Nieweg, Sydney Ch’ng, W. Martin C. Klop, Andrew J. Spillane, Georgina V. Long, Richard A. Scolyer, Bart A. van de Wiel, Christian U. Blank

    المساهمون: Oral and Maxillofacial Surgery

    المصدر: JAMA Surgery, 157(4), 335-342. AMER MEDICAL ASSOC
    JAMA surgery, 157(4), 335-342. American Medical Association

    مصطلحات موضوعية: Male, Skin Neoplasms, Pilot Projects, Middle Aged, Ipilimumab, Neoadjuvant Therapy, Nivolumab, Humans, Lymph Node Excision, Female, Surgery, Lymph Nodes, Prospective Studies, Neoplasm Recurrence, Local, Melanoma, Neoplasm Staging, Retrospective Studies

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83255a1603596ffca3ab7f4e60dc4be4Test
    https://doi.org/10.1001/jamasurg.2021.7554Test


    أضف إلى المفضلة
  9. 9
    Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy☆

    المؤلفون: Michael Millward, V. Atkinson, Sandip Pravin Patel, Christoph Hoeller, Christian U. Blank, Andrew Haydon, Alexander N. Shoushtari, Reinhard Dummer, Alexander M. Menzies, James Larkin, Carina N. Owen, Arissa Young, Maartje W. Rohaan, Dharmisha Chauhan, Shahneen Sandhu, Douglas B. Johnson, J. Mangana, Georgina V. Long, D. Palmieri, Matteo S. Carlino, Serigne Lo, Muhammad A. Khattak, Farzana Y Zaman, Peter Hersey, Belinda Lee

    المصدر: Ann Oncol

    مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Ipilimumab, Gastroenterology, Article, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Adjuvant therapy, Humans, Stage (cooking), Melanoma, Hematology, business.industry, Mucosal melanoma, medicine.disease, Combined Modality Therapy, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Cutaneous melanoma, Immunotherapy, business, Adjuvant, medicine.drug

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b83e339b674f679f965aaea6b9ddf88Test
    https://doi.org/10.1016/j.annonc.2020.04.471Test


    أضف إلى المفضلة
  10. 10
    Prognostic and predictive value of beta-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

    المؤلفون: Oliver J. Kennedy, Michal Kicinski, Sara Valpione, Sara Gandini, Stefan Suciu, Christian U. Blank, Georgina V. Long, Victoria G. Atkinson, Stéphane Dalle, Andrew M. Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Rutger Koornstra, Leonel Hernandez-Aya, Anna M. Di Giacomo, Alfonsus J.M. van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Alexander C.J. van Akkooi, Caroline Robert, Alexander M.M. Eggermont, Paul Lorigan, Mario Mandala

    المصدر: European Journal of Cancer, 165, 97-112
    European Journal of Cancer, 165, pp. 97-112
    Kennedy, O J, Kicinski, M, Valpione, S, Gandini, S, Suciu, S, Blank, C U, Long, G V, Atkinson, V G, Dalle, S, Haydon, A M, Meshcheryakov, A, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, Di Giacomo, A M, van den Eertwegh, A J M, Grob, J J, Gutzmer, R, Jamal, R, van Akkooi, A C J, Robert, C, Eggermont, A M M, Lorigan, P & Mandala, M 2022, ' Prognostic and predictive value of β-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma ', European Journal of Cancer, vol. 165, pp. 97-112 . https://doi.org/10.1016/j.ejca.2022.01.017Test

    مصطلحات موضوعية: Cancer Research, Skin Neoplasms, Adrenergic beta-Antagonists, Medizin, Antibodies, Monoclonal, Humanized, Adrenergic beta-antagonists, Beta-blockers, Immunomodulation, Immunotherapy, Melanoma, Adjuvants, Immunologic, Humans, Neoplasm Staging, Prognosis, Tumor Microenvironment, Antibodies, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], All institutes and research themes of the Radboud University Medical Center, Immunologic, Monoclonal, Adjuvants, Humanized, Manchester Cancer Research Centre, ResearchInstitutes_Networks_Beacons/mcrc, Oncology

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d75ba607dbd7225632c8df9aab98b7d3Test
    http://hdl.handle.net/2066/250190Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث